Upstream Bio (UPB) Assets Average (2024 - 2026)

Upstream Bio's Assets Average history runs 3 years deep, the most recent figure standing at $335.9 million for Q1 2026.

• In Q1 2026, Assets Average fell 28.37% year-over-year to $335.9 million; the TTM figure through Mar 2026 stood at $335.9 million (down 28.37% YoY), while the FY2025 annual figure was $417.7 million, up 39.5% from the prior year.
• Assets Average was $335.9 million for Q1 2026 at Upstream Bio, down from $372.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $468.9 million in Q1 2025 to a low of $335.9 million in Q1 2026.
• Historically, Assets Average has averaged $396.5 million across 3 years, with a median of $389.2 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Assets Average grew 4.28% in 2025, then dropped 28.37% in 2026.
• A 3-year view of Assets Average shows it stood at $357.2 million in 2024, then grew by 4.28% to $372.5 million in 2025, then decreased by 9.82% to $335.9 million in 2026.
• The last three Assets Average figures came in at $335.9 million (Q1 2026), $372.5 million (Q4 2025), and $405.9 million (Q3 2025), per Business Quant data.